| EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
LIN10 |
C16orf6, C16orf70: UPF0183 protein C16orf70 |
0.278 |
Evidence |
|
| RPL10 |
RPL10, DXS648E, QM: 60S ribosomal protein L10 |
SCCPDH |
SCCPDH, CGI-49: Probable saccharopine dehydrogenase |
0.278 |
Evidence |
|
| GNAI2 |
Galphai2 protein |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.278 |
Evidence |
|
| MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.278 |
Evidence |
|
| ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.278 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.278 |
Evidence |
|
| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.278 |
Evidence |
|
| TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.278 |
Evidence |
|
| DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.278 |
Evidence |
|
| CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.278 |
Evidence |
|
| EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.278 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.278 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
SCML2 |
SCML2: Sex comb on midleg-like protein 2 |
0.278 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.278 |
Evidence |
|
| CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
0.278 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
GNAI2 |
Galphai2 protein |
0.278 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.278 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.278 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
GNAI2 |
Galphai2 protein |
0.278 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.278 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.278 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.278 |
Evidence |
O
|
| OXTR |
OXTR: Oxytocin receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.278 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
GNAI2 |
Galphai2 protein |
0.278 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.278 |
Evidence |
|